Found 32 matching trials
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma PHASE3 The purpose of this study was to evaluate safety and efficacy of the combin...
Show More Location
California Cancer Associates for Research and Excellence
Learn More & Join Trial
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors PHASE1 To assess safety and tolerability, describe the dose-limiting toxicities, a...
Show More Learn More & Join Trial
A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) PHASE2 The BeeHive study is an investigator-initiated, single center, open-label p...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Microbiome Immunotherapy Toxicity and Response Evaluation N/A This is a observational study to investigate how the microbiome correlates ...
Show More Location
Royal United Hospitals Bath NHS Foundation Trust
Learn More & Join Trial
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free. PHASE3 Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, mul...
Show More Location
Hospital General Universitario de Alicante
Learn More & Join Trial
Safety and Efficacy Study of IMSA101 in Refractory Malignancies PHASE1 Open-label, dose escalation (Phase I) and dose expansion (Phase IIA) study ...
Show More Learn More & Join Trial
Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma PHASE2 The primary objective of this clinical trial is to evaluate the clinical ef...
Show More Location
Providence Portland Medical Center
Learn More & Join Trial
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment N/A This is a prospective, non-interventional, observational study evaluating t...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade PHASE2 The study is an interventional phase II clinical trial aiming to evaluate t...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. PHASE2 This is a single arm Phase 2 study of the combination of adenoviral p53 (Ad...
Show More Location
Robert H. Lurie Comprehensive Cancer Center | Northwestern University
Learn More & Join Trial